Fedha

Hisa unazofuatilia
ABVX:NASDAQ
Abivax SA
US$ 83.16
-0.80%
(-0.67) Siku 1
19 Nov, 12:57:13 GMT -5  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya ABVX...
Fungua
US$ 83.73
Juu
US$ 86.93
Chini
US$ 82.89
Mtaji wa soko
6.67B
Wastani wa kiasi cha mauzo
elfu 948.97
Kiasi cha mauzo ya hisa
1.21M
Juu kwa wiki 52
US$ 148.83
Chini kwa wiki 52
US$ 69.81
Beta
1.36
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Fungua
US$ 83.73
Juu
US$ 86.93
Chini
US$ 82.89
Mtaji wa soko
6.67B
Wastani wa kiasi cha mauzo
elfu 948.97
Kiasi cha mauzo ya hisa
1.21M
Juu kwa wiki 52
US$ 148.83
Chini kwa wiki 52
US$ 69.81
Beta
1.36
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Kuhusu Abivax SA
Afisa Mkuu Mtendaji (CEO)Marc de Garidel | Hartmut J. Ehrlich
Wafanyakazi98
Lilianzishwa4 Des 2013
Makao makuu-
SektaHealth Care
Sekta-
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 9 waliotoa ukadiriaji wa hisa kwa ABVX katika miezi 3 iliyopita
Imenunuliwa sana
Nunua
8
Shikilia
1
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 9 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya ABVX katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 83.16
US$ 180.00 (+116.45%)
Wastani
US$ 160.56 (+93.07%)
Chini kabisa
US$ 118.00 (+41.90%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Allison Bratzel
Piper Sandler
Buy
Maintained
US$ 175.00
+110.4%
10/21/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
US$ 175.00
+110.4%
10/20/2026
Etzer Darout
Barclays
Buy
Maintained
US$ 148.00
+78%
10/20/2026
Julian Harrison
BTIG
Buy
Reiterated
US$ 175.00
+110.4%
10/01/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
US$ 180.00
+116.5%
09/28/2026
David Nierengarten
Wedbush
Hold
Maintained
US$ 118.00
+41.9%
09/22/2026
Gregory Renza
Truist Financial
Buy
Maintained
US$ 151.00
+81.6%
09/22/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
US$ 168.00
+102%
09/22/2026
Rajan Sharma
Goldman Sachs
Buy
Initiated
US$ 155.00
+86.4%
09/09/2026
Faisal Khurshid
Jefferies
Buy
Upgraded
US$ 158.00
+90%
07/01/2026
Andy Chen
Wolfe Research
Buy
Reiterated
US$ 136.00
+63.5%
06/03/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$ 140.00
+68.4%
06/02/2026
Jason Butler
Citizens JMP
Buy
Maintained
US$ 187.00
+124.9%
06/02/2026
Ripoti za awaliThamani zote katika EUR
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika EUR
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
elfu 639.00
1.91M
1.34M
elfu 976.00
Gharama ya bidhaa zilizouzwa
-
-
-
-
Gharama ya mapato
-
-
-
-
Gharama za utafiti na maendeleo
55.42M
44.40M
49.54M
58.34M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
27.34M
27.69M
8.03M
26.98M
Gharama ya uendeshaji
81.35M
73.56M
57.57M
85.09M
Jumla ya gharama za uendeshaji
81.35M
73.56M
57.57M
85.09M
Mapato ya uendeshaji
-80.71M
-71.65M
-56.23M
-84.11M
Mapato mengine yasiyo ya uendeshaji
-74.20M
-4.96M
elfu 119.00
4.72M
EBT ikijumuisha vipengee visivyo vya kawaida
-153.36M
-76.11M
-48.24M
-123.51M
EBT bila kujumuisha vipengee visivyo vya kawaida
-153.36M
-80.84M
-51.51M
-80.30M
Gharama ya kodi ya mapato
-
5.85M
elfu 228.00
-6.08M
Kiwango cha kodi kinachotumika
-
-7.68%
-0.47%
4.92%
Gharama nyingine za uendeshaji
-1.40M
1.47M
-
elfu -225.00
Mapato halisi
-153.36M
-81.96M
-48.47M
-117.43M
Kiwango cha faida halisi
-23,999.69%
-4,282.13%
-3,606.25%
-12,032.07%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
3.36M
1.19M
elfu 644.00
-
Gharama ya riba
-4.21M
-15.27M
-2.54M
elfu -730.00
Jumla ya gharama halisi za riba
elfu -852.00
-14.08M
-1.90M
elfu -730.00
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-80.63M
-70.76M
-56.14M
-84.02M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Matukio yajayo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google